Cerebral blood flow as a biomarker of resilience in cognitively unimpaired APOE ɛ4 carriers.

Melanie Quiring; Arunima Kapoor; John Paul M Alitin; Basant Lashin; Jillian L Joyce; Allison C Engstrom; Trevor Lohman; Aimée Gaubert; Fatemah Shenasa; Kevin W Law; Farrah Ferrer; Danny J J Wang; Elizabeth Head; Rond Malhas; Kathleen Rodgers; S Duke Han; Daniel A Nation

doi:10.1002/alz.71934

SCHEDA SCIENTIFICA2026Altra ricerca

Cerebral blood flow as a biomarker of resilience in cognitively unimpaired APOE ɛ4 carriers.

Melanie Quiring, Arunima Kapoor, John Paul M Alitin, Basant Lashin, Jillian L Joyce, Allison C Engstrom, Trevor Lohman, Aimée Gaubert, Fatemah Shenasa, Kevin W Law, Farrah Ferrer, Danny J J Wang, Elizabeth Head, Rond Malhas, Kathleen Rodgers, S Duke Han, Daniel A Nation

Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

Psicologia cognitiva Psicodiagnostica

Abstract e pubblicazione originale

L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.

Leggi nella fonte originale ↗

Parole chiave

HumansApolipoprotein E4Cerebrovascular CirculationFemaleAgedMagnetic Resonance ImagingMaleBiomarkersTemporal LobeExecutive FunctionCognitionHeterozygotetau ProteinsNeuropsychological TestsAlzheimer DiseaseAPOEcerebral blood flowcognitive resilienceexecutive functionhyperperfusionplasma p‐tau217preclinical Alzheimer's disease

Come citare questo studio

Melanie Quiring, Arunima Kapoor, John Paul M Alitin, Basant Lashin, Jillian L Joyce, Allison C Engstrom, Trevor Lohman, Aimée Gaubert, Fatemah Shenasa, Kevin W Law, Farrah Ferrer, Danny J J Wang, Elizabeth Head, Rond Malhas, Kathleen Rodgers, S Duke Han, Daniel A Nation. (2026). Cerebral blood flow as a biomarker of resilience in cognitively unimpaired APOE ɛ4 carriers.. Alzheimer's & dementia : the journal of the Alzheimer's Association. DOI: 10.1002/alz.71934

Consulta la pubblicazione originale ↗